Abstract
We thus proposed and validated a dosage prediction algorithm for anticoagulated patients having stable INR. We evaluated the contribution of genetic and non-genetic factors to dosage variability. The estimated regression equation accounted for 44.4% of total variability in regard to warfarin maintenance dose. Our study gives the first description and validation of an algorithm for predicting warfarin dosing maintenance for a cohort of the Colombian patients and provides a starting point for future initiatives involving increased patient panel size. The results presented here should be used and monitored by doctors working in public and private medical institutions.
| Translated title of the contribution | Creation and validation of a pharmacogenetic dosing algorithm for Warfarin in patients treated at Méderi |
|---|---|
| Original language | Spanish (Colombia) |
| Pages | 1-1 |
| Number of pages | 1 |
| State | Submitted - Dec 5 2018 |
| Event | III Encuentro de Investigación CIMED - Bogota, Colombia Duration: Dec 5 2018 → Dec 5 2018 |
Conference
| Conference | III Encuentro de Investigación CIMED |
|---|---|
| Country/Territory | Colombia |
| City | Bogota |
| Period | 12/5/18 → 12/5/18 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Genetics
Fingerprint
Dive into the research topics of 'Creation and validation of a pharmacogenetic dosing algorithm for Warfarin in patients treated at Méderi'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver